MBX Biosciences Closes $34.6 Million Series A Financing in Rare Endocrine Diseases

Monday, July 27, 2020 1 min read

Key Takeaway: MBX Biosciences Closes $34.6 Million Series A Financing in Rare Endocrine Diseases

Full Press Release Details

MBX Biosciences Closes $34.6 Million Series A Financing in Rare Endocrine Diseases.